Kevin  Waters net worth and biography

Kevin Waters Biography and Net Worth

EVP, CFO of PROCEPT BioRobotics
Mr. Waters has served as our EVP, Chief Financial Officer since January 2022. He previously served as our SVP, Chief Financial Officer from October 2018 until December 2021. Prior to joining PROCEPT BioRobotics Mr. Waters served as Chief Financial Officer at Accuray Inc., a radiation oncology company, from September 2015 to October 2018. In addition to his experience at Accuray, Inc., Mr. Waters held financial leadership positions at three publicly traded medical device companies, including Conceptus, Laserscope and VISX. These companies were all sold to strategic acquirers, generating approximately $3 billion in shareholder value. Mr. Waters began his career at PricewaterhouseCoopers, LLP. and received a B.S. in Business Administration, with a double concentration in Accounting and Finance from Cal Poly San Luis Obispo

What is Kevin Waters' net worth?

The estimated net worth of Kevin Waters is at least $9.27 million as of October 15th, 2024. Mr. Waters owns 96,096 shares of PROCEPT BioRobotics stock worth more than $9,271,342 as of December 4th. This net worth approximation does not reflect any other investments that Mr. Waters may own. Additionally, Mr. Waters receives an annual salary of $680,110.00 as EVP, CFO at PROCEPT BioRobotics. Learn More about Kevin Waters' net worth.

How old is Kevin Waters?

Mr. Waters is currently 47 years old. There are 5 older executives and no younger executives at PROCEPT BioRobotics. The oldest executive at PROCEPT BioRobotics is Dr. Reza Zadno Ph.D., President, CEO & Director, who is 69 years old. Learn More on Kevin Waters' age.

What is Kevin Waters' salary?

As the EVP, CFO of PROCEPT BioRobotics Co., Mr. Waters earns $680,110.00 per year. The highest earning executive at PROCEPT BioRobotics is Dr. Reza Zadno Ph.D., President, CEO & Director, who commands a salary of $1,130,000.00 per year. Learn More on Kevin Waters' salary.

How do I contact Kevin Waters?

The corporate mailing address for Mr. Waters and other PROCEPT BioRobotics executives is 900 ISLAND DRIVE, REDWOOD CITY CA, 94065. PROCEPT BioRobotics can also be reached via phone at 650-232-7200 and via email at [email protected]. Learn More on Kevin Waters' contact information.

Has Kevin Waters been buying or selling shares of PROCEPT BioRobotics?

Over the course of the past ninety days, Kevin Waters has sold $1,811,750.00 in shares of PROCEPT BioRobotics stock. Most recently, Kevin Waters sold 25,000 shares of the business's stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $72.47, for a transaction totalling $1,811,750.00. Following the completion of the sale, the chief financial officer now directly owns 96,096 shares of the company's stock, valued at $6,964,077.12. Learn More on Kevin Waters' trading history.

Who are PROCEPT BioRobotics' active insiders?

PROCEPT BioRobotics' insider roster includes Antal Desai (Director), Frederic Moll (Director), Alaleh Nouri (EVP), Hisham Shiblaq (EVP, Chief Commercial Officer), Kevin Waters (EVP, CFO), and Reza Zadno (CEO). Learn More on PROCEPT BioRobotics' active insiders.

Are insiders buying or selling shares of PROCEPT BioRobotics?

In the last twelve months, insiders at the sold shares 34 times. They sold a total of 973,143 shares worth more than $70,081,453.91. The most recent insider tranaction occured on November, 27th when CEO Reza Zadno sold 26,420 shares worth more than $2,584,668.60. Insiders at PROCEPT BioRobotics own 17.4% of the company. Learn More about insider trades at PROCEPT BioRobotics.

Information on this page was last updated on 11/27/2024.

Kevin Waters Insider Trading History at PROCEPT BioRobotics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/15/2024Sell25,000$72.47$1,811,750.0096,096View SEC Filing Icon  
9/16/2024Sell25,000$82.51$2,062,750.0096,096View SEC Filing Icon  
3/18/2024Sell1,024$48.83$50,001.92102,149View SEC Filing Icon  
3/6/2024Sell3,435$46.67$160,311.4549,416View SEC Filing Icon  
2/12/2024Sell22,349$50.16$1,121,025.8433,523View SEC Filing Icon  
2/9/2024Sell28,677$50.09$1,436,430.9333,523View SEC Filing Icon  
2/7/2024Sell904$50.00$45,200.0033,523View SEC Filing Icon  
1/9/2024Sell17,310$45.07$780,161.7033,523View SEC Filing Icon  
12/13/2023Sell71,465$40.05$2,862,173.2533,523View SEC Filing Icon  
12/8/2023Sell6,888$40.02$275,657.7633,523View SEC Filing Icon  
12/6/2023Sell4,360$40.02$174,487.2044,248View SEC Filing Icon  
6/15/2023Sell22,631$35.12$794,800.7233,523View SEC Filing Icon  
3/16/2023Sell706$31.84$22,479.0456,154View SEC Filing Icon  
3/7/2023Sell7,954$34.25$272,424.5056,860View SEC Filing Icon  
See Full Table

Kevin Waters Buying and Selling Activity at PROCEPT BioRobotics

This chart shows Kevin Waters's buying and selling at PROCEPT BioRobotics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

PROCEPT BioRobotics Company Overview

PROCEPT BioRobotics logo
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Read More

Today's Range

Now: $96.48
Low: $93.28
High: $97.41

50 Day Range

MA: $84.56
Low: $66.83
High: $99.27

2 Week Range

Now: $96.48
Low: $36.52
High: $103.81

Volume

485,633 shs

Average Volume

654,822 shs

Market Capitalization

$5.03 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.99